Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod ® brand of products, today announced its new campaign, "The Day ...

The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its ...

Insulet (($PODD)) announced an update on their ongoing clinical study. Insulet Corporation is conducting a clinical study titled ‘Safety and ...

Insulet (($PODD)) announced an update on their ongoing clinical study. Insulet Corporation has announced a new clinical study titled ‘Omnipod 5 – ...

Cameras were rolling at a “Holiday Nights” party with Urban Outfitters last week hosted by the show’s cast members.

Dexcom is facing scrutiny and class-action lawsuits over alleged safety and accuracy issues with its G7 monitor.

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, will host an Investor Day at the Company’s Acton ...

New findings published in Nature Medicine showed that people can enter prediabetes remission — and lower type 2 diabetes risk ...

-Seasoned Executive with Proven Track Record in International Pump Launches to Accelerate Global Adoption of User Friendly, Affordable Patch Pumps SAN DIEGO, CA / ACCESS Newswire / October 6, 2025 / ...

Toymaker Mattel has launched its latest addition to the Barbie range of dolls, the first with type 1 diabetes, which comes complete with a wearable continuous glucose monitor (CGM) and insulin pump.

DexCom receives a BUY rating due to strong growth, expanding margins, and the launch of Stelo, the first OTC CGM for non-insulin users. DXCM raised its 2025 outlook, targeting $4.6B+ in revenue, 62% ...